Jason Lettmann - 17 Feb 2026 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Shelly Pinto, by power of attorney
Issuer symbol
ALXO
Transactions as of
17 Feb 2026
Net transactions value
-$4,996
Form type
4
Filing time
19 Feb 2026, 21:02:25 UTC
Previous filing
28 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lettmann Jason CHIEF EXECUTIVE OFFICER, Director C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO /s/ Shelly Pinto, by power of attorney 19 Feb 2026 0001688269

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Tax liability $4,996 -2,201 -0.71% $2.27 305,920 17 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
F2 Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2025.